HB5050

Health: pharmaceuticals; administration of epinephrine; modify. Amends secs. 17744a & 17744d of 1978 PA 368 (MCL 333.17744a & 333.17744d). TIE BAR WITH: HB 5054'25, HB 5049'25, HB 5051'25, HB 5052'25, HB 5053'25

Chamber Passed·12/17/25

Michigan HB5050 modifies laws on epinephrine administration, clarifying immunity and liability for authorized entities and individuals.

Michigan HB5050 amends sections of the Public Health Code to modify the administration of epinephrine. It provides immunity from civil and criminal liability for authorized entities and individuals who administer epinephrine in good faith, unless the conduct constitutes willful or wanton misconduct. The bill also outlines training requirements for those administering epinephrine and mandates reporting of incidents to the Department of Health and Human Services. It specifies that immunity does not limit other available defenses and does not apply to gross negligence.

Included in complete analysis

  • Overview
  • Core Provisions
  • Implementation
  • Impact
  • Legal Framework
  • Critical Issues

See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.

Where it stands

Last
Passed the House · 103–0 · Dec 17, 2025
Current
Health Policy Committee
Next
Senate floor vote

Sponsors

DDDDDDD
7
13
RRRRRRRRRRRRR
Democratic CaucusRepublican Caucus

Roll Call Votes

103 Yea

RDRDRRRRDRRRDDRRRDDRRDDDRRRRDRRDDRDRDRRDDDRRRRDRDDDRRDRDDRDRRRRDDRRDRDRRDDRRRDDRDRDDDRRDRDDRRRRRRDDDDRD

0 Nay

Calendar

Jun 17

1:00 PM

Senate Health Policy

Dec 16, 2025

1:45 PM

House Rules

History

Jan 14

Senate

Passed By House With Immediate Effect

Jan 14

Senate

Referred To Committee On Health Policy

Dec 17, 2025

House

Read A Second Time